Paper of the Year Awards Grant

Paper of the Year Awards Grant

Status: ACTIVE
Funder: Oligonucleotide Therapeutics Society
Amount: US $1,000
Last Updated: February 28, 2026

Summary

The Oligonucleotide Therapeutics Society (OTS) presents the Paper of the Year Awards to acknowledge groundbreaking research in oligonucleotide therapeutics. Established in 2002, the OTS aims to foster collaboration among scientists to advance the field. Awards are given in two categories: Basic Research and Late Discovery, recognizing impactful studies from July to June of the preceding year. Recipients receive a $1,000 USD award and a certificate during the OTS Annual Meeting, celebrating contributions to this innovative therapeutic area.

Overview

About the Oligonucleotide Therapeutics Society (OTS) The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities, very much like the impact that antibodies had on human therapeutics over the last decade. Incorporated in the State of Massachusetts in 2002 and granted 501(c)6 nonprofit status with the United States Internal Revenue Service in 2003, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics. The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas. Paper of the Year Awards Paper of the Year Awards are designed to honor the most impactful papers in the field of oligonucleotide therapeutics. There are two categories for Paper of the Year Awards reflecting the scope of excellent research being done in the field of oligonucleotide therapeutics: Basic Research – Paper must be on a Basic Research (pre-clinical) topic relevant to oligonucleotide therapeutics Late Discovery – Paper must be on a Late Discovery (large pre-clinical models and clinical studies) topic relevant to oligonucleotide therapeutics Recipients receive: $1,000 USD award Presentation of an award certificate at the OTS Annual Meeting

Eligibility

You can learn more about this opportunity by visiting the funder's website. Papers must be published between July – June preceding the current year’s Annual Meeting. For 2025 awards, papers must be published between July 2024 – June 2025.